Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations.
暂无分享,去创建一个
G Scott Gazelle | James E Stahl | K. Furie | G. Gazelle | J. Stahl | Karen L Furie | Suzanne Gleason | S. Gleason | James E. Stahl
[1] M. Lipton. Intracranial aneurysms. , 1997, The New England journal of medicine.
[2] Peter P. Wakker,et al. The Utility of Health States After Stroke: A Systematic Review of the Literature , 2001, Stroke.
[3] G. Hankey,et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, Journal of the American Medical Association (JAMA).
[4] S. Hallan,et al. Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes , 1999, Journal of internal medicine.
[5] K. Welch,et al. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1997, Archives of neurology.
[6] J. Kostis,et al. Delay in presentation and evaluation for acute stroke : Stroke time registry for outcomes knowledge and epidemiology (S. T. R. O. K. E.) , 2001 .
[7] G. Azzimondi,et al. Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. , 1997, Stroke.
[8] J. Lee,et al. Patient Preferences for Stroke Outcomes , 1994, Stroke.
[9] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[10] M. Kaste,et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.
[11] Joseph S. Pliskin,et al. Health Economic Evaluations: The Special Case of End-Stage Renal Disease Treatment , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] M. Hommel,et al. Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.
[13] R. Luepker,et al. Delayed Hospital Arrival for Acute Stroke: The Minnesota Stroke Survey , 1998, Annals of Internal Medicine.
[14] Erry,et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.
[15] H. Glick,et al. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. , 1995, Journal of neurosurgery.
[16] W. Rosamond,et al. Determinants of Use of Emergency Medical Services in a Population With Stroke Symptoms: The Second Delay in Accessing Stroke Healthcare (DASH II) Study , 2000, Stroke.
[17] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[18] R. Fogelholm,et al. Factors delaying hospital admission after acute stroke. , 1996, Stroke.
[19] W. Thies,et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.
[20] J. Grotta,et al. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Stroke.
[21] E. Nussbaum,et al. Cost-effectiveness of carotid endarterectomy. , 1996, Neurosurgery.
[22] M. Alberts,et al. An analysis of time of presentation after stroke. , 1990, JAMA.
[23] R. Knill-Jones,et al. Observer variability in assessing impaired consciousness and coma. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[24] M. Kaste,et al. Where and how should elderly stroke patients be treated? A randomized trial. , 1995, Stroke.
[25] G. Chapman,et al. [Medical decision making]. , 1976, Lakartidningen.
[26] N A Azimi,et al. The effectiveness of cost-effectiveness analysis in containing costs , 1998, Journal of general internal medicine.
[27] W. Rosamond,et al. Time delays in accessing stroke care in the emergency department. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[28] W. Rosamond,et al. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[29] J. Broderick,et al. Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.
[30] P. Duncan,et al. Defining post-stroke recovery: implications for design and interpretation of drug trials , 2000, Neuropharmacology.
[31] R. O’Connor,et al. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. , 1999, Annals of emergency medicine.
[32] S. Hallan,et al. A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke , 1999, Journal of internal medicine.
[33] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[34] A. Dávalos,et al. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. , 1995, Stroke.
[35] M. Malkoff,et al. Code stroke. An attempt to shorten inhospital therapeutic delays. , 1994, Stroke.
[36] P A Wolf,et al. Survival and recurrence following stroke. The Framingham study. , 1982, Stroke.
[37] J. Streifler,et al. Factors Associated with the Time of Presentation of Acute Stroke Patients in an Israeli Community Hospital , 1998, Neuroepidemiology.
[38] J. Lewin,et al. Cost-effectiveness of emergency intraarterial intracerebral thrombolysis: a pilot study. , 1995, AJNR. American journal of neuroradiology.
[39] J R Beck,et al. Management of Unruptured Intracranial Aneurysm in Japan , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[40] D K Owens,et al. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.
[41] J Lipscomb,et al. Inpatient costs of specific cerebrovascular events at five academic medical centers. , 1996, Neurology.
[42] M. Alexander. Stroke Rehabilitation Outcome: A Potential Use of Predictive Variables to Establish Levels of Care , 1994, Stroke.
[43] Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group. , 1995, Lancet.
[44] J. Kostis,et al. Delay in Presentation and Evaluation for Acute Stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.) , 1997, Stroke.
[45] F. Mahoney,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.
[46] Averill M. Law,et al. Simulation Modeling and Analysis , 1982 .
[47] T. Brott,et al. Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.
[48] P. Wester,et al. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study.Seek- Medical-Attention-in-Time Study Group. , 1999, Stroke.
[49] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[50] L. McCaig,et al. National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. , 2001, Advance data.
[51] C. Chudnofsky,et al. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[52] Joann E D’Esposito. Bureau of Labor Statistics Web Site , 2000 .
[53] Tammy O. Tengs,et al. Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.
[54] J. Broderick,et al. Epidemiological Characteristics of Lacunar Infarcts in a Population , 1991, Stroke.
[55] J. Banks,et al. Handbook of Simulation , 1998 .
[56] J. Broderick,et al. Acute stroke: delays to presentation and emergency department evaluation. , 1999, Annals of emergency medicine.
[57] A. Folsom,et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.
[58] J. Sinacore,et al. Stroke Inpatient Rehabilitation: A Comparison across Age Groups , 1994, Journal of the American Geriatrics Society.
[59] W. Rosamond,et al. Stroke symptom attribution and time to emergency department arrival: the delay in accessing stroke healthcare study. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[60] T. Olsen,et al. The effect of a stroke unit: reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. , 1995, Stroke.
[61] H. Adams,et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.
[62] A. Demchuk,et al. Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project , 2002, Stroke.
[63] P D Lyden,et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Circulation.
[64] T O Tengs,et al. Health-related quality of life after stroke a comprehensive review. , 2001, Stroke.
[65] W. O'Fallon,et al. Utilization of acute care services in the year before and after first stroke: A population-based study. , 1996, Neurology.
[66] S. Fagan,et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. , 1999, Neurology.
[67] GiuseppeAzzimondi,et al. Variables Associated With Hospital Arrival Time After Stroke , 1997 .
[68] A. Dávalos,et al. Delay in Neurological Attention and Stroke Outcome , 1995 .
[69] Richard P. Nathan,et al. Sharing the Burden: Strategies for Public and Private Long-Term Care Insurance , 1994 .
[70] S. Ebrahim. Systematic review of cost-effectiveness research of stroke evaluation and treatment. , 1999, Stroke.
[71] R. Sacco,et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community , 1994, Neurology.
[72] Carl V. Granger,et al. Discharge Outcome After Stroke Rehabilitation , 1992, Stroke.
[73] S. Schappert,et al. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.
[74] W. Rosamond,et al. Prehospital and Emergency Department Delays After Acute Stroke: The Genentech Stroke Presentation Survey , 2000, Stroke.
[75] Joseph H. Huber,et al. Poststroke rehabilitation in older Americans. The Medicare experience. , 1996, Medical care.